Breast cancer and systemic sclerosis: A clinical description of 21 patients in a population-based cohort study

Rheumatology International

Volumn 28, Issue 9, 2008, Pages 895-899

  Lu, Tim Y T ^a   Hill, Catherine L ^b   Pontifex, Eliza K ^c   Roberts Thomson, Peter J ^c  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b QUEEN ELIZABETH HOSPITAL   (Australia)

^c FLINDERS MEDICAL CENTRE   (Australia)

Author keywords

Breast cancer; Systemic sclerosis

Indexed keywords

CENTROMERE ANTIBODY;

ADULT; ARTICLE; AUSTRALIA; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PATIENT; CANCER REGISTRY; CANCER SCREENING; CHI SQUARE TEST; COHORT ANALYSIS; FAMILY HISTORY; FEMALE; FISHER EXACT TEST; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; METHODOLOGY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RANK SUM TEST; RISK FACTOR; SCLERODERMA; SEROLOGY; SOLID TUMOR; SYMPTOM; SYSTEMIC SCLEROSIS;

ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HUMANS; MIDDLE AGED; REGISTRIES; SCLERODERMA, SYSTEMIC; SOUTH AUSTRALIA;

EID: 49949152358     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-008-0540-9     Document Type: Article

References (18)

1. Rosenthal AK, McLaughlin JK, Gridley G, Nyren O (1995) Incidence of cancer among patients with systemic sclerosis. Cancer 76:910-914
2. Yang Y, Fujita J, Tokuda M, Bandoh S, Ishida T (2001) Lung cancer associated with several connective tissue diseases: with a review of literature. Rheumatol Int 21:106-111
3. Launay D, Le Berre R, Hatron PY, Peyrat JP, Hachulla E, Devulder B et al. (2004) Association between systemic sclerosis and breast cancer: eight new cases and review of literature. Clin Rheumatol 23:516-522
4. Scope A, Sadetzki S, Sidi Y, Barzilai A, Trau H, Kaufman B et al (2006) Breast cancer and scleroderma. Skinmed 5:18-24
5. Hill CL, Nguyen AM, Roder D, Roberts-Thomson PJ (2003) Risk of cancer in patients with scleroderma: a population-based cohort study. Ann Rheum Dis 62:728-731
6. Roberts-Thomson PJ, Nikoloutopoulos T, Cox S, Walker JG, Gordon TP (2003) Antinuclear antibody testing in a regional laboratory. Immunol Cell Biol 81:409-412
7. Masi AT, Rodnan GP, Medsger TA, Altman RD, D'Angelo WA, Fries JF et al (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581-590
8. Roberts-Thomson PJ, Jones M, Hakendorf P, Kencana Dharmapatni AASS, Walker JG, MacFarlane JG et al (2001) Scleroderma in South Australia: epidemiological observations of possible pathogenic significance. Int Med J 31:220-229
9. Bonett A, Roder D, Milliken L (1992) The South Australian Cancer Registry: a means of assessing cancer incidence, mortality and case survival. Eur J Cancer 28A:1923-1926
10. Derk CT (2007) Associations of breast cancer development in patients with systemic sclerosis: an exploratory study. Clin Rheumatol 26(10):1615-1619 Epub 2 Feb 2007
11. Klippel JH, Crofford LJ, Stone JH, Weyand CM (2001) Primer on the rheumatic diseases, 12th edn. Arthritis Foundation Publishing Department, Atlanta, p 353
12. Forbes AM, Woodrow JC, Verbov JL, Graham RM (1989) Carcinoma of breast and scleroderma: four further cases and a literature review. Br J Rheumatol 28:65-69
13. Hasset C, Harnett P, Manolios N (2001) Scleroderma in association with the use of docetaxel (taxotere) for breast cancer. Clin Exp Rheumatol 19:197-200
14. Abu-Shakra M, Guillemin F, Lee P (1993) Cancer in systemic sclerosis. Arthritis Rheum 36:460-464
15. Kochhar R, Umbreit JN (2004) Fatal exacerbation of paraneoplastic systemic sclerosis after neoadjuvant chemotherapy in a breast cancer patient. Clin Rheumatol 23:269-271
16. Alexandrescu DT, Bhagwati NS, Wiernik PH (2005) Chemotherapy-induced scleroderma: a pleiomorphic syndrome. Clin Dermatol 30:141-145
17. Querfeld C, Collbeg S, Huerkamp C, Eckes B, Krieg T (2000) Pseudoscleroderma associated with lung cancer: correlation of collagen type 1 and connective tissue growth factor gene expression. Br J Dermatol 142:1128-1133
18. Askling J (2007) Malignancy and rheumatoid arthritis. Curr Rheumatol Rep 9(5):421-6